Skip to main content
. 2022 Apr 13;2022:9872788. doi: 10.1155/2022/9872788

Table 5.

Effects of H. sabdariffa calyxes extract on some hematological parameters after 21 weeks post-DMBA exposition.

Parameters NOR DMBA TAMOX + DMBA H. sabdariffa + DMBA
125 250 500
WBC (×103µL−1) 10.60 ± 1.09 21.56 ± 1.96## 12.00 ± 1.91 14.99 ± 2.61 25.14 ± 3.45 12.00 ± 1.78
Lymphocytes (%) 78.04 ± 2.56 43.81 ± 6.55### 70.02 ± 5.26∗∗ 58.5 ± 6.98 33.24 ± 2.05 68.22 ± 4.70∗∗
Monocytes (%) 19.21 ± 2.71 47.14 ± 5.45### 16.12 ± 4.30∗∗∗ 8.53 ± 1.78∗∗∗ 37.86 ± 6.37 26.81 ± 4.38
Granulocytes (%) 0.86 ± 0.17 0.34 ± 0.04 1.31 ± 0.13∗∗ 1.5 ± 0.19∗∗∗ 0.53 ± 0.16 1.3 ± 0.23∗∗
RBC (×103µL−1) 8.16 ± 0.69 5.82 ± 0.50 7.58 ± 0.34 7.85 ± 1.64 3.96 ± 0.77 6.41 ± 0.99
Hematocrite (%) 46.1 ± 3.18 30.75 ± 3.68 38.86 ± 4.19 36.7 ± 3.94 26.26 ± 4.73 36.08 ± 3.71
MCV (fL) 57.41 ± 2.33 59.96 ± 2.610 56.28 ± 0.95 65.41 ± 3.01 68.45 ± 4.18 59.9 ± 1.50
Platelets(×103µL−1) 574.57 ± 34.38 461.8 ± 50.09 614.93 ± 18.46 423.4 ± 122.32 449.33 ± 77.48 479.8 ± 56.15
MCH (pg) 18.62 ± 1.59 16.06 ± 0.58 17.51 ± 0.36 23.61 ± 7.23 16.61 ± 0.48 17.86 ± 1.01
Hemoglobin (g/dL) 14.64 ± 0.71 9.31 ± 1.13## 12.06 ± 1.31 10.68 ± 0.93 5.5 ± 0.96 11.03 ± 1.55
MCHC (g/dL) 32.17 ± 1.25 27.23 ± 1.15## 31.18 ± 0.67 27.18 ± 0.93 24.61 ± 0.92 27.31 ± 1.03
IG (%) 0.12 ± 0.04 0.6 ± 0.23 0.32 ± 0.11 1.03 ± 0.30 0.9 ± 0.27 0.15 ± 0.06

NOR = Animals serving as normal control and receiving distilled water (vehicle); DMBA = Animals serving as negative control and receiving distilled water (vehicle); TAMOX + DMBA = Animals serving as positive control and receiving tamoxifen at a dose of 3.3 mg/kg; and H. sabdariffa + DMBA = Animals receiving H. sabdariffa calyxes extract at doses of 125, 250, and 500 mg/kg. All animals except those in the normal group (NOR) were exposed to a single dose of DMBA (50 mg/kg; s.c.). #p < 0.05, ##p < 0.01; ###p < 0.001 compared to the NOR group; p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 compared to the DMBA group.